Amgen has terminated its rocatinlimab collaboration with Kyowa Kirin, walking away from the anti-OX40 antibody five years after paying $400 million for rights to the autoimmune disease drug candidate.
How-To Geek on MSN
How I built the perfect programming platform in under 10 minutes
Building your perfect programming environment is easier than you think. Here's how to do it in minutes!
My 5 favorite Linux distros that are ready to use out of the box (no setup required) ...
Jason Chun is a CNET writer covering a range of topics in tech, home, wellness, finance and streaming services. He is passionate about language and technology, and has been an avid writer/reader of ...
Java Development Kit (JDK) 26, a planned update to standard Java due March 17, 2026, has reached its second release candidate (RC) stage. The RC is open for critical bug fixes, with the feature set ...
When the IBM PC was new, I served as the president of the San Francisco PC User Group for three years. That’s how I met PCMag’s editorial team, who brought me on board in 1986. In the years since that ...
Shelby Putnam Tupper is founder and creative director of Shelby Designs Inc., a small-but-mighty, full-service, customer-obsessed design consultancy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results